2024-06-20
-
Ceutical innovation of LakeShore
benefits the health of humanity -
LakeShore strives for perfection,
pursues excellence,
and creates tomorrow together
To safeguard the human health
Through unremitting long-term efforts, we aim to become a domestic leading and internationally renowned innovative vaccine corporate.
Rigorous and pragmatic, Striving for perfection, Pursuing excellence, Collaborating for mutual benefit.
LakeShore Biopharma (Nasdaq:LSB, formerly YS) is a developer and manufacturer of human-used vaccines and other immune products. At present, the main product under sale is freeze-dried human rabies vaccine (Vero cells), and the cumulative sales of this product since its launch have exceeded 80 million units.The therapeutic PIKA rabies vaccine (Vero cells) jointly developed by the corporate is a major new drug development project of Ministry of Science and Technology of Ch
